Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’

Por Huo, Teh-Ia, Liu, Po-Hong, Hsu, Chia-Yang
Publicado no Br J Cancer (2017)

ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Is It Sufficient?

Por Huo, Teh-Ia, Liu, Po-Hong, Hsu, Chia-Yang
Publicado no Liver Cancer (2017)

Adherence to a Healthy Lifestyle is Associated with a Lower Risk of Diverticulitis among Men

Por Liu, Po-Hong, Cao, Yin, Keeley, Brieze R., Tam, Idy, Wu, Kana, Strate, Lisa L., Giovannucci, Edward L., Chan, Andrew T.
Publicado no Am J Gastroenterol (2017)

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System

Por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado no Medicine (Baltimore) (2015)

Retrospective cause analysis of troponin I elevation in non-CAD patients: Special emphasis on sepsis

Por Yang, Chien-Wen, Li, Huijun, Thomas, Lisa, Ramos, Manuel, Liu, Po-Hong, Roe, Thomas, Valadri, Ravinder, Kiel, Michael C., Su, Vincent Yi-Fong, Shi, Qi
Publicado no Medicine (Baltimore) (2017)

A de novo assembly of the sweet cherry (Prunus avium cv. Tieton) genome using linked-read sequencing technology

Por Jiawei Wang, Weizhen Liu, Dongzi Zhu, Xiang Zhou, Po Hong, Hongjun Zhao, Yue Tan, Xin Chen, Xiaojuan Zong, Li Xu, Lisi Zhang, Hairong Wei, Qingzhong Liu
Publicado em 2020-06-01

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma

Por Hsu, Chia-Yang, Liu, Po-Hong, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Nagaria, Teddy S., Lee, Rheun-Chuan, Ho, Shu-Yein, Hou, Ming-Chih, Huo, Teh-Ia
Publicado no Sci Rep (2017)

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.

Por Yu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Shu-Yein Ho, Ming-Chih Hou, Harn-Shen Chen, Teh-Ia Huo
Publicado em 2017-01-01

Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?

Por Chia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Yi-Hsiang Huang, Han-Chieh Lin, Yi-You Chiou, Fa-Yauh Lee, Teh-Ia Huo
Publicado em 2015-01-01

In vivo assessment of macrophage CNS infiltration during disruption of the blood–brain barrier with focused ultrasound: a magnetic resonance imaging study

Por Liu, Hao-Li, Wai, Yau-Yau, Hsu, Po-Hong, Lyu, Lee-Ang, Wu, Jia-Shin, Shen, Chia-Rui, Chen, Jin-Chung, Yen, Tzu-Chen, Wang, Jiun-Jie
Publicado em 2010

In vivo assessment of macrophage CNS infiltration during disruption of the blood–brain barrier with focused ultrasound: a magnetic resonance imaging study

Por Liu, Hao-Li, Wai, Yau-Yau, Hsu, Po-Hong, Lyu, Lee-Ang, Wu, Jia-Shin, Shen, Chia-Rui, Chen, Jin-Chung, Yen, Tzu-Chen, Wang, Jiun-Jie
Publicado em 2010

Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model

Por Hsu, Chia-Yang, Lee, Yun-Hsuan, Liu, Po-Hong, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado em 2014

Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?

Por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado no PLoS One (2015)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis

Por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado no Medicine (Baltimore) (2014)

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology

Por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Su, Chien-Wei, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado no Medicine (Baltimore) (2015)

Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

Por Liu, Po-Hong, Su, Chien-Wei, Hsu, Chia-Yang, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Lee, Rheun-Chuan, Lin, Han-Chieh, Huo, Teh-Ia
Publicado no PLoS One (2016)

When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy

Por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado no Medicine (Baltimore) (2015)

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective

Por Su, Yu-Wen, Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Ho, Shu-Yein, Hou, Ming-Chih, Chen, Harn-Shen, Huo, Teh-Ia
Publicado no PLoS One (2017)

A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems.

Por Yun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, Po-Hong Liu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo
Publicado em 2014-01-01

A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems

Por Lee, Yun-Hsuan, Hsu, Chia-Yang, Chu, Chen-Wei, Liu, Po-Hong, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado em 2014